“Changes in management team position WELL for the next phase of growth.”
Vancouver, B.C. April 30, 2019 – WELL Health Technologies Corp. (the ‘Company’ or ‘WELL’), (TSX.V:WELL) announced today the appointment of Eva Fong as its Chief Financial Officer (‘CFO’) effective immediately. Ms. Fong will assume the CFO role from Brian Levinkind, who is transitioning to the position of Senior Vice President of Corporate Development. The Company is also pleased to announce the appointment of Pardeep Sangha as VP Corporate Strategy and Investor Relations.
“This re-configuration of Brian and Eva’s roles better positions WELL to tackle the rapid growth trajectory WELL is embarking on. We are fortunate to have such outstanding professionals on our senior leadership team”, said Hamed Shahbazi, Chairman and Chief Executive Officer of WELL. “In addition, we are excited to be adding Pardeep to the WELL team as his experience and network in the capital markets will be an invaluable asset to the Company. We have assembled a very experienced management team to lead WELL into its next stage of growth.“
Ms. Fong was previously the Senior Vice President of M&A and Business Transformation at WELL where she successfully led the Company through the acquisition and integration of medical clinics and NerdEMR, as well as implementing shared services functions. Ms. Fong has over 20 years of finance and technology industry experience which includes public company management, M&A of many large scale transactions, corporate strategy development, risk and compliance, and business shared services programs. She has held leadership positions in various high-tech companies including PayPal, TIO Networks, SAP, and 360networks. ”I am thrilled to be leading the strong financial stewardship Brian has built,” said Ms. Fong. “I look forward to driving financial strategies and shared services that lead to improved operations which positively impact health outcomes.”
In his new role, Mr. Levinkind will be responsible for corporate development focusing on strategic initiatives such as partnerships, joint ventures, equity investments and acquisitions. Mr. Levinkind has previously been involved in the planning, structuring, and implementation of numerous financings, mergers, acquisitions, and corporate reorganizations, many in the healthcare sector, which makes him an ideal candidate in his new role at WELL. “I am excited to be an integral part of the experienced team focused on the continuation of the Company’s impressive growth trajectory,” said Mr. Levinkind.
Mr. Sangha joins WELL after a successful career as a top ranked Canadian technology sector analyst. Mr. Sangha previously spent over three years as the Senior Technology Analyst at Haywood Securities and eight years at PI Financial Corp. He is a well recognized analyst who received a StarMine ranking in both 2012 and 2014. Mr. Sangha has also had venture capital, engineering and operations experience prior to his career as a technology sector analyst. “I am pleased to be joining the amazing executive team at WELL, and look forward to helping the Company with its strategic growth initiatives and investor relations activities,” said Mr. Sangha.
About WELL
WELL is a unique company that operates Primary Healthcare Facilities as well as a significant EMR or Electronic Medical Records business that supports the digitization of such clinics. WELL’s overarching objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health. In the last 12 months, WELL physicians served approximately 600,000 patient visits through its network of 19 medical clinics. WELL is publicly traded on the Exchange under the symbol WELL.V. WELL Health Technologies was recognized as a TSX Venture 50 Company in 2018 and 2019.
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
For further information:
Pardeep S. Sangha
VP Corporate Strategy and Investor Relations
pardeep.sangha@well.company
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Disclaimer for Forward-Looking Information
Certain statements in this news release related to the Company are forward-looking statements and are prospective in nature. Forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events, and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding: the acquisition of NerdEMR and Butterfly; establishing best in class shared services to create a scalable growth model for the Company; modernizing the Company’s operation with the use of technology to benefit doctors and patients; improving the patient journey and elevating clinical outcomes; delivering superior shareholder value over the short and long term; scaling the Company’s operations through the implementation of technology; obtaining operational efficiencies and improved health outcomes; expected number of patient visits, and executing on a disciplined and highly accretive capital allocation program. There are numerous risks and uncertainties that could cause actual results and WELL’s plans and objectives to differ materially from those expressed in the forward-looking information, including: (i) adverse market conditions; (ii) risks inherent in the primary healthcare sector in general; and (iii) other factors beyond the control of the Company. Actual results and future events could differ materially from those anticipated in such information. These and all subsequent written and oral forward-looking information are based on estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Except as required by law, the Company does not intend to update these forward-looking statements.
